Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas

被引:33
|
作者
Finn, Olivera J. [1 ]
Gantt, Kira R. [1 ]
Lepisto, Andrew J. [1 ]
Pejawar-Gaddy, Sharmila [1 ]
Xue, Jia [1 ]
Beatty, Pamela L. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA
关键词
Lung cancer; Pancreatic cancer; Cancer vaccine; Tumor-associated antigens; Mucin; CARCINOMA-ASSOCIATED ANTIGEN; BETA-CATENIN; C-SRC; CANCER; GROWTH; CELLS; TRANSCRIPTION; PROTEIN; IMMUNITY; STRESS;
D O I
10.1007/s12026-011-8214-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many important aspects of cancer biology, such as cancer initiation, progression, and metastasis, have been studied in animal models, mostly mice. As long as cancer was considered primarily a genetic disease, the study of transplantable mouse tumors, or even human tumor xenografts in immunocompromised mice, appeared to suffice. Many important genetic events that lead to transformation and in vivo tumor growth were elucidated. However, many even more important factors that determine whether or not the genetic potential of a tumor cell will be realized, such as the host response to the tumor and the tumor microenvironment that influences this response over a long period of time of tumor development, remained untested and unappreciated. This is slowly changing with the advent of molecular techniques that have spurred efforts to engineer better mouse models of human tumors. In this review, we show results of our efforts to combine a genetic mouse model of spontaneous human adenocarcinomas based on a Kras mutation, with an important human molecule MUC1 that is abnormally expressed on human adenocarcinomas, promoting oncogenesis, proinflammatory tumor microenvironment, and immunosurveillance.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 50 条
  • [41] The multifaceted role of MUC1 in tumor therapy resistance
    Weiqiu Jin
    Mengwei Zhang
    Changzi Dong
    Lei Huang
    Qingquan Luo
    Clinical and Experimental Medicine, 2023, 23 : 1441 - 1474
  • [42] The multifaceted role of MUC1 in tumor therapy resistance
    Jin, Weiqiu
    Zhang, Mengwei
    Dong, Changzi
    Huang, Lei
    Luo, Qingquan
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (05) : 1441 - 1474
  • [43] Expression of MUC1 on corneal endothelium of human
    Jung, SE
    Seo, KY
    Kim, H
    Kim, HL
    Chung, IH
    Kim, EK
    CORNEA, 2002, 21 (07) : 691 - 695
  • [44] NOVEL CAR T THAT TARGETS MUC1*NOT FULL-LENGTH MUC1 FOR TREATMENT OF SOLID TUMOR CANCERS
    Bamdad, C.
    Stewart, A. K.
    Smagghe, B. J.
    Huang, P.
    Glennie, N. D.
    Deary, L. T.
    CYTOTHERAPY, 2018, 20 (05) : S7 - S7
  • [45] Recombinant human tumor antigen MUC1 expressed in insect cells: Structure and immunogenicity
    Soares, M
    Hanisch, FG
    Finn, OJ
    Ciborowski, P
    PROTEIN EXPRESSION AND PURIFICATION, 2001, 22 (01) : 92 - 100
  • [46] Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
    Yokoyama, Seiya
    Higashi, Michiyo
    Kitamoto, Sho
    Oeldorf, Monika
    Knippschild, Uwe
    Kornmann, Marko
    Maemura, Kosei
    Kurahara, Hiroshi
    Wiest, Edwin
    Hamada, Tomofumi
    Kitazono, Ikumi
    Goto, Yuko
    Tasaki, Takashi
    Hiraki, Tsubasa
    Hatanaka, Kazuhito
    Mataki, Yuko
    Taguchi, Hiroki
    Hashimoto, Shinichi
    Batra, Surinder K.
    Tanimoto, Akihide
    Yonezawa, Suguru
    Hollingsworth, Michael A.
    ONCOTARGET, 2016, 7 (27) : 42553 - 42565
  • [47] Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
    N Bizouarne
    P Squiban
    B Acres
    JM Balloul
    MA Ohresser
    R Figlin
    A Belldegrun
    R Herrman
    C Rochlitz
    Breast Cancer Research, 3 (Suppl 1)
  • [48] Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with MUC1-C3d fusion protein
    Ohta, Rieko
    Imai, Masaki
    He, Chun
    Ross, Ted M.
    Tomlinson, Stephen
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 221 - 221
  • [49] Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells
    Gong, JL
    Chen, DS
    Kashiwaba, M
    Li, YQ
    Chen, L
    Takeuchi, H
    Qu, H
    Rowse, GJ
    Gendler, SJ
    Kufe, D
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) : 6279 - 6283
  • [50] Expression of MUC1 mucin on activated human T cells: Implications for a role of MUC1 in normal immune regulation
    Agrawal, B
    Krantz, MJ
    Parker, J
    Longenecker, BM
    CANCER RESEARCH, 1998, 58 (18) : 4079 - 4081